Cyclosporine Dosage for Toxic Epidermal Necrolysis
For toxic epidermal necrolysis (TEN), cyclosporine should be administered at 3 mg/kg/day orally, divided into two doses (1.5 mg/kg twice daily), for 10 days, then tapered over the following weeks.
Evidence-Based Dosing Protocol
The most consistent dosing regimen across clinical studies for TEN is:
- Initial dose: 3 mg/kg/day divided into two oral doses
- Duration: 10 days at full dose
- Tapering: Gradual reduction over 2-4 weeks after the initial 10-day period
- Route: Oral administration (even in critically ill patients, enteral administration is feasible)
Clinical Context and Rationale
The UK guidelines for SJS/TEN management acknowledge cyclosporine as a studied intervention, with the most robust evidence supporting the 3 mg/kg/day dosing regimen 1. The landmark French study by Valeyrie-Allanore demonstrated zero mortality in 29 patients treated with this protocol, compared to a SCORTEN-predicted mortality of 2.75 deaths 1, 2. A Spanish burn unit series using the same 3 mg/kg/day dosing showed significantly faster disease arrest (1.4 vs 3.6 days) and complete re-epithelialization (12.0 vs 17.6 days) compared to historical controls 3.
Treatment Timing and Monitoring
Start cyclosporine as early as possible - ideally within 2-3 days of disease onset. Early administration (on day of admission) has been associated with:
- Reduced in-hospital mortality by 6%
- Decreased 30-day mortality by 3%
- Faster cessation of disease progression 4, 5
Monitor for:
- Renal function (serum creatinine) - dose reduction or discontinuation if significant elevation occurs
- Blood pressure - hypertension is a common adverse effect
- Signs of infection - though recent data suggests cyclosporine may actually reduce systemic infection rates compared to other immunosuppressive regimens 5
Important Caveats
Conflicting evidence exists: A large French retrospective study of 174 patients found no benefit from cyclosporine using propensity score matching, and noted increased acute renal failure 6. However, this study had methodological limitations including lack of randomization and potential selection bias.
Do not confuse TEN dosing with other dermatologic conditions: The evidence provided includes cyclosporine dosing for psoriasis (2.5-5 mg/kg/day), atopic dermatitis (3-5 mg/kg/day), and nephrotic syndrome (3-4 mg/kg/day), but these are different clinical contexts with different treatment durations 7, 8, 7, 9.
Pediatric considerations: Limited pediatric data supports the same 3-5 mg/kg/day dosing range, though one recent case series used this successfully in children who failed high-dose corticosteroids plus IVIG 10.
Practical Administration
- Cyclosporine can be given enterally even in critically ill burn unit patients
- The oral solution should be diluted with orange or apple juice (avoid grapefruit juice due to drug interactions)
- Administer in two divided doses 12 hours apart
- Treatment duration of 10 days at full dose appears optimal, with longer courses not providing additional benefit and potentially increasing toxicity risk
The 3 mg/kg/day regimen represents the best balance between efficacy and safety based on available evidence, though definitive randomized controlled trials are still needed 1, 11.